CureDuchenne, a national nonprofit raising awareness and funds to cure Duchenne muscular dystrophy, brought its fight to Cambridge on Oct. 20 for inaugural event Dealing for Duchenne. Held in the lobby of 650 E. Kendall St., the casino night honored Lou Kunkel, the Harvard Stem Cell Institute researcher who discovered the gene and encoded protein, dystrophin, that is mutated in boys with Duchenne. The 250 guests helped raise $125,000.
Search for a Photo or Category
CureDuchenne’s Dealing for Duchenne
By Dana Bisbee | Nov. 23, 2016
Meg Wood, eastern director of development at CureDuchenne, and Sal Zinno, director of leasing and development at BioMed Realty Trust, at Dealing for Duchenne on Oct. 20.
Pam Nettles-Gomez, director of ambulatory operations at Boston Medical Center, and Morgan Weinstein, associate at BioMed Realty Trust, at Dealing for Duchenne on Oct. 20.
Elizabeth Goldman, realtor at Goldman Real Estate, and Audrey Markoff, channel marketing manager at Ping Identity, at Dealing for Duchenne on Oct. 20.
Jak Knowles, managing director of CureDuchenne Ventures, and wife Lauren Knowles at Dealing for Duchenne on Oct. 20.
Event honoree Lou Kunkel, director of the genomics program at the Harvard Stem Cell Institute, daughter Johanna Kunkel, assistant store manager at Lululemon Athletica, and wife Sue Kunkel, at Dealing for Duchenne on Oct. 20.
CureDuchenne, a national nonprofit raising awareness and funds to cure Duchenne muscular dystrophy, brought its fight to Cambridge on Oct. 20 for inaugural event Dealing for Duchenne. Held in the lobby of 650 E. Kendall St., the casino night honored Lou Kunkel, the Harvard Stem Cell Institute researcher who discovered the gene and encoded protein, dystrophin, that is mutated in boys with Duchenne. The 250 guests helped raise $125,000.
Related Galleries
NMO Awareness Gala
View Gallery
A Taste of Ginger
View Gallery
Catwalk for the Cure
View Gallery
View All Events